Literature DB >> 27588908

Cutting back on the carbs.

Vivian H Trang1, Peter D Senter2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27588908      PMCID： PMC5027411          DOI： 10.1073/pnas.1612432113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  28 in total

Review 1.  Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds.

Authors:  Robert G Spiro
Journal:  Glycobiology       Date:  2002-04       Impact factor: 4.313

2.  Superior in vivo efficacy of afucosylated trastuzumab in the treatment of HER2-amplified breast cancer.

Authors:  Teemu T Junttila; Kathryn Parsons; Christine Olsson; Yanmei Lu; Yan Xin; Julie Theriault; Lisa Crocker; Oliver Pabonan; Tomasz Baginski; Gloria Meng; Klara Totpal; Robert F Kelley; Mark X Sliwkowski
Journal:  Cancer Res       Date:  2010-05-18       Impact factor: 12.701

Review 3.  Immune checkpoint blockade: a common denominator approach to cancer therapy.

Authors:  Suzanne L Topalian; Charles G Drake; Drew M Pardoll
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

4.  Precision glycocalyx editing as a strategy for cancer immunotherapy.

Authors:  Han Xiao; Elliot C Woods; Petar Vukojicic; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

Review 5.  A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics.

Authors:  Haike Ghazarian; Brian Idoni; Steven B Oppenheimer
Journal:  Acta Histochem       Date:  2010-03-02       Impact factor: 2.479

6.  Sialylation of 3-methylcholanthrene-induced fibrosarcoma determines antitumor immune responses during immunoediting.

Authors:  Merav Cohen; Moshe Elkabets; Michal Perlmutter; Angel Porgador; Elena Voronov; Ron N Apte; Rachel G Lichtenstein
Journal:  J Immunol       Date:  2010-10-18       Impact factor: 5.422

7.  Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma.

Authors:  Rostyslav Bilyy; Andriy Tomin; Iryna Mahorivska; Olga Shalay; Volodymyr Lohinskyy; Rostyslav Stoika; Yuriy Kit
Journal:  J Mol Recognit       Date:  2010-11-16       Impact factor: 2.137

8.  Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function.

Authors:  Qun Zhou; Srinivas Shankara; Andre Roy; Huawei Qiu; Scott Estes; Alison McVie-Wylie; Kerry Culm-Merdek; Anna Park; Clark Pan; Tim Edmunds
Journal:  Biotechnol Bioeng       Date:  2008-02-15       Impact factor: 4.530

Review 9.  Antiviral agents active against influenza A viruses.

Authors:  Erik De Clercq
Journal:  Nat Rev Drug Discov       Date:  2006-12       Impact factor: 84.694

10.  Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion.

Authors:  Jason E Hudak; Stephen M Canham; Carolyn R Bertozzi
Journal:  Nat Chem Biol       Date:  2013-11-24       Impact factor: 15.040
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.